Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026)
Syndax Pharmaceuticals (SNDX) recorded quarterly Revenue of $64.9 million in Q1 2026, down 5.62% quarter-over-quarter from $68.7 million in Q4 2025, and up 223.64% on a YoY basis from $20.0 million in Q1 2025.
Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Revenue history runs 10 years deep, the most recent figure standing at $64.9 million for Q1 2026.
- In Q1 2026, Revenue rose 223.64% year-over-year to $64.9 million; the TTM figure through Mar 2026 stood at $217.4 million (up 397.28% YoY), while the FY2025 annual figure was $172.4 million, up 627.84% from the prior year.
- Revenue was $64.9 million for Q1 2026 at Syndax Pharmaceuticals, down from $68.7 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $68.7 million in Q4 2025 to a low of $3.5 million in Q2 2024.
- Historically, Revenue has averaged $32.6 million across 3 years, with a median of $29.0 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Revenue jumped 984.51% in 2025, then jumped 223.64% in 2026.
- A 3-year view of Revenue shows it stood at $7.7 million in 2024, then soared by 794.9% to $68.7 million in 2025, then dropped by 5.62% to $64.9 million in 2026.
- The last three Revenue figures came in at $64.9 million (Q1 2026), $68.7 million (Q4 2025), and $45.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.69 Bn | 1.34 Bn | 53.02 Mn | 64.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.86 Mn |
| Dec 31, 2025 | 68.73 Mn |
| Sep 30, 2025 | 45.87 Mn |
| Jun 30, 2025 | 37.96 Mn |
| Mar 31, 2025 | 20.04 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Dec 31, 2021 | 126.58 Mn |
| Sep 30, 2021 | 12.38 Mn |
| Jun 30, 2021 | 379,000.00 |
| Mar 31, 2021 | 379,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Sep 30, 2020 | 379,000.00 |
| Jun 30, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Sep 30, 2019 | 379,000.00 |
| Jun 30, 2019 | 379,000.00 |
| Mar 31, 2019 | 379,000.00 |